Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples